Infertility affects approximately one in six individuals worldwide and is associated with significant psychological distress, particularly among women undergoing treatment. Increased anxiety levels are strongly linked to reduced quality of life during the infertility process. With the growing integration of artificial intelligence (AI) into healthcare, AI-based tools are increasingly used in infertility care to support decision-making and patient engagement. While many patients are familiar with AI technologies, individual attitudes toward AI may influence their acceptance and potential psychosocial benefits. This study aims to examine the relationship between attitudes toward artificial intelligence, anxiety levels, and quality of life among women undergoing infertility treatment.

Inclusion Criteria:

• Women aged 18-45 years diagnosed with infertility (primary or secondary infertility).
• Women undergoing infertility treatment and those who have experienced various treatment modalities (IUI, IVF, ICSI).
• Women who voluntarily agree to participate in the study.
• Women who are able to understand and speak Turkish.

Exclusion Criteria:

• Women with diagnosed psychological disorders (e.g., clinical depression, anxiety disorders).
• Women who are not undergoing infertility treatment.

Women aged 18-45 years diagnosed with primary or secondary infertility and currently undergoing infertility treatment (IUI, IVF, or ICSI).

Individual participant data (IPD) will not be publicly shared due to privacy concerns and the sensitive nature of maternal and infant health information. However, anonymized data may be made available upon reasonable request to the corresponding author after publication of the study results.